8-K 1 a23899e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 26, 2006
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
         
Delaware   0-11634   95-3797439
         
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)
         
1911 Walker Ave, Monrovia,        
California       91016
         
(Address of principal executive offices)       (Zip Code)
Registrant’s telephone number, including area code: 626-303-7902
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 7.01 Regulation FD Disclosure.
SIGNATURES
Exhibit Index
EXHIBIT 99.1

Table of Contents

Item 7.01 Regulation FD Disclosure.
     David Bailey, President and CEO of STAAR Surgical Company, intends to make a slide presentation at private investor meetings in New York, New York and Boston, Massachusetts on September 26, 2006 and September 27, 2006, and at the UBS Global Life Sciences Conference s in New York at 12:30 p.m. local time on September 28, 2006. A copy of the slide presentation is furnished with this report as Exhibit 99.1.
     As STAAR has previously announced, while attendance is by invitation only, an audio-only webcast of STAAR’s presentation at the UBS Global Life Sciences Conference may be accessed through the Company’s website at www.staar.com. An archived replay of the presentation will be available approximately 3 hours after the live presentation and can also be accessed at www.staar.com.

 

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  STAAR Surgical Company
 		  
September 26, 2006  By:   /s/ David Bailey    
    Name:   David Bailey   
    Title:   President and Chief
Executive Officer 		  
 

 

Table of Contents

Exhibit Index
     
Exhibit No.   Description
99.1
  Slide Presentation, September 26, 2006.